Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2010
11/23/2010US7838658 siRNA silencing of filovirus gene expression
11/23/2010US7838657 compositions capable of blocking the inhibitory effect of a newly-identified intronic inhibitory sequence element, named ISS-N1 (intronic splicing silencer), located in the SMN2 gene
11/23/2010US7838655 Oligonucleotide sequence formula for labeling oligonucleotide probes and proteins for in-situ analysis
11/23/2010US7838654 Tubulin regulatory elements for use in plants
11/23/2010US7838653 Regulatory elements associated with CBF transcription factor of rye
11/23/2010US7838652 Polynucleotides for expression transgene in plants
11/23/2010US7838651 nucleotide sequences comprising a Yarrowia genetic translation initiation site, for encoding desaturases
11/23/2010US7838650 Expression vector comprising nucleotide sequences which code plant regulatory sequences; for use in controlling root length, senecense and/or water and nutrient uptake
11/23/2010US7838649 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms ; plants and microorganisms that produce lipids
11/23/2010US7838648 Purified SR-p70 protein
11/23/2010US7838647 Non-invasive detection of fetal genetic traits
11/23/2010US7838645 Function of autophagy genes in cell death
11/23/2010US7838640 Method of producing cell extract for cell-free protein synthesis
11/23/2010US7838639 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival
11/23/2010US7838637 Single-chain multiple antigen-binding molecule, its preparation and use
11/23/2010US7838636 for diagnosing, treating, preventing and/or prognosing disorders related to these novel polypeptides; for genetic diseases such as muscular dystrophy and cystic fibrosis
11/23/2010US7838635 CD16A binding proteins and use for the treatment of immune disorders
11/23/2010US7838632 Maize cellulose synthases and uses thereof
11/23/2010US7838506 nonpeptidic inhibitors of cathepsin G; genetic diseases, degenerative diseases, DNA damages, neoplasia and/or skin diseases; DNA or polynucleotide sequences having a chain length of at least 60 nucleotides and being substantially not subjected to undergo efficient base pairing
11/23/2010US7838505 using hybrid Hepatocyte Growth Factor (HGF) construct for prevention and treatment of ischemic and liver disorders
11/23/2010US7838504 Reducing flavivirus or Hepatitis virus replication in vitro or vivo by inhibiting activity of a microRNA; administering an antisense oligonucleotide complementary to microR-122
11/23/2010US7838501 chimera; nuclear factor kappa beta; vectors, host cell; gene therapy; pharmacokinetics
11/23/2010US7838466 Device for chemical and biochemical reactions using photo-generated reagents
11/23/2010US7838295 Homologous recombination mediated transgene deletion in plant cells
11/23/2010US7838294 Inhibitors of the JNK signal transduction pathway and methods of use
11/23/2010US7838293 insecticidal activity of the protein against Lepidopteran pests (moths); biological pesticides
11/23/2010US7838290 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
11/23/2010US7838289 Assay utilizing multipotent adult stem cells
11/23/2010US7838287 Library of a collection of cells
11/23/2010US7838279 Production of isoprenoids
11/23/2010US7838278 Compositions and methods for manipulating carbon flux in cells
11/23/2010US7838277 Viral vector comprising adenovirus capsid gene sequences for use as tool for delivery and expression of heterologous gene sequences in cells
11/23/2010US7838276 Carbohydrate utilization-related and multidrug transporter nucleic acids and polypeptides; producing a polypeptide by culturing a microbial cell that has beta-galactosidase activity; Lactobacillus acidophilus
11/23/2010US7838274 polynucleotides encoding the phospholipases; using these enzymes in industrial processes and methods of diagnosing fungal infections; Aspergillus niger; recombinant host cells wherein the expression of a phospholipase is significantly increased or wherein the activity of the phospholipase is increased
11/23/2010US7838268 selectively modulating NF (Nuclear Factor)- kappa B dependent gene transcription in a cell comprised of modulating I kappa B kinase (IKK) alpha protein activity in the cell
11/23/2010US7838266 A purified pro-cytolytic peptide; used to treat localized and metastatic prostate cancer; administered intratumorally and/or intraprostatically
11/23/2010US7838255 Nucleic acids and polypeptides of C1 bacteriophage and uses thereof
11/23/2010US7838254 G protein-coupled receptor (GPCR); conditions modulated by stimulation of NPY Y2 receptor (Y2R) including bone-related conditions, metabolic disorders, angiogenesis-related conditions, ischemia-related conditions, convulsive disorders, malabsorptive disorders, cancers, and inflammatory disorders
11/23/2010US7838253 Using cold and menthol-sensitive receptor (CMR1) polypeptide as diagnostic tool in identifying modulators for treatment of pain and cold sensitivity
11/23/2010US7838251 Nuclear matrix protein CC2 specfic immunoglobulin for use as evaluative tool in diagnosis of cell proliferative disorders of colon
11/23/2010US7838248 anti-IL-18 Receptor accessory protein antibody; used in the study of cell signaling in response to IL-18 stimulation, and inducible protein expression systems based on the involvement of ACPL polypeptides in cell signaling
11/23/2010US7838247 determination of the Alzheimer Related Membrane Protein (ARMP) gene on chromosome 14 and a related gene, E5-1, on chromosome 1; diagnosing Alzheimer's disease
11/23/2010US7838244 staphylococcal exotoxin-like proteins (SETs); for identification and/or isolation of IgA and the scrum complement factor C5
11/23/2010US7838243 Protein forming complex with c-Jun protein, nucleic acid encoding the same and method of using the same
11/23/2010US7838241 Genotyping methods using genomic sequence of the 5-lipoxygenase-activating protein (FLAP) and polymorphic markers thereof
11/23/2010US7838224 sensitive methods to measure mRNA levels in biopsied tumor tissues, including archived paraffin-embedded biopsy material; predicting the likelihood of long-term survival without recurrence of breast cancer
11/23/2010US7838219 Method of increasing complementarity in a heteroduplex
11/23/2010US7838207 Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease
11/23/2010US7838053 Barley for production of flavor-stable beverage
11/23/2010US7838003 For diagnostic, prophylactic and therapeutic uses; vaccines
11/23/2010US7838002 decrease inhibit or prevent viral propagation or screening of compounds impaction on the expression of shorter form core+1 protein; antiviral agents
11/23/2010CA2512701C Improved method for reverse transcription
11/23/2010CA2461068C Cell populations which co-express cd49c and cd90
11/23/2010CA2444529C Micellar drug delivery systems for hydrophobic drugs
11/23/2010CA2384355C Methods and means for modification of plant flowering characteristics
11/23/2010CA2378147C Electrical impedance tomography to control electroporation
11/23/2010CA2378113C Controlled electroporation and mass transfer across cell membranes
11/23/2010CA2343655C Interleukin 17-like receptor protein
11/23/2010CA2337981C Gene participating in the production of homoglutamic acid and its use
11/23/2010CA2315271C Platelet derived growth factor (pdgf) nucleic acid ligand complexes
11/23/2010CA2295189C Type-1 ribosome-inactivating protein
11/23/2010CA2263823C Mammalian artificial chromosomes
11/23/2010CA2252565C Dna vaccine formulations
11/23/2010CA2232738C Strategy for suppressing the expression of an endogenous gene
11/23/2010CA2222140C Packaging systems for human recombinant adenovirus to be used in gene therapy
11/23/2010CA2209301C Redirection of cellular immunity by protein-tyrosine kinase chimeras
11/23/2010CA2200610C Transgenic animals expressing human coagulation factor viii and von willebrand factor
11/23/2010CA2169292C Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
11/23/2010CA2158791C Dna sequences encoding the machado-joseph disease gene and uses thereof
11/18/2010WO2010132742A1 Methods and compositions for modulating erbb2 activity
11/18/2010WO2010132708A2 Modulation of terminase activity at telomeres and dna double-strand breaks
11/18/2010WO2010132665A1 Gemm riboswitches, structure-based compound design with gemm riboswitches, and methods and compositions for use of and with gemm riboswitches
11/18/2010WO2010132609A2 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
11/18/2010WO2010132341A2 Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein
11/18/2010WO2010132214A1 Environmental stress-inducible promoter and its application in crops
11/18/2010WO2010132112A2 Immunogenic compositions against tuberculosis
11/18/2010WO2010132092A2 Cytidine deaminase fusions and related methods
11/18/2010WO2010132019A1 Gene synthesis method
11/18/2010WO2010131960A2 New fungal elicitor protein and its use as resistance marker
11/18/2010WO2010131946A1 New fungal elicitor protein and its use as resistance marker
11/18/2010WO2010131916A2 Sirna conjugate and preparation method thereof
11/18/2010WO2010131907A2 Sirna delivery system using self-assembled polymeric nanoparticles
11/18/2010WO2010131835A2 Method for polymerizing a small oligonucleotide, and use of a high-molecular oligonucleotide prepared by the polymerization method
11/18/2010WO2010131777A1 Fine particles of crystalline polyol and method of preparing same
11/18/2010WO2010131748A1 Aptamer that recognizes peptide
11/18/2010WO2010131747A1 Virus-producing cell
11/18/2010WO2010131704A1 Test agent for visceral obesity and use thereof
11/18/2010WO2010131703A1 NOVEL PPARγ PROMOTER SEQUENCE AND USE APPLICATION THEREOF
11/18/2010WO2010131695A1 Modified double-stranded rna
11/18/2010WO2010131645A1 Method for synthesis of double-stranded dna corresponding to rna, and method for amplification of the dna
11/18/2010WO2010131590A1 Diagnostic agent and therapeutic agent for tumors
11/18/2010WO2010131491A1 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
11/18/2010WO2010131452A1 Ttk peptides and vaccines including the same
11/18/2010WO2010131315A1 Induced mesenchymal stem cell and process for production thereof
11/18/2010WO2010131285A1 Murine model for male infertility obtained by glucocorticoid-induced leucine zipper gene inactivation, method for the preparation and relative uses
11/18/2010WO2010131195A1 Phosphodiesterase 4d7 as prostate cancer marker
11/18/2010WO2010131194A1 Phosphodiesterase 4d7 as marker for malignant, hormone-sensitive prostate cancer
11/18/2010WO2010131193A1 Phosphodiesterase 9a as prostate cancer marker
11/18/2010WO2010131115A1 Modified fluorescent proteins and methods for using same
11/18/2010WO2010130898A2 Menigococcus vaccine containing lipooligosaccharide (los) from modified strains of l6 immunotype neisseria meningitidis